ASHKELON, Israel, Nov. 20, 2013 /PRNewswire/ -- How often a person with diabetes must monitor his or her blood sugar is not one-size-fits- all. Factors that play into physician recommendations include type and severity of diabetes, age, duration of disease, presence of diabetic complications and overall health. However, people don't always take good advice to heart and act on it, even from a respected physician—and even when failing to comply can be life-threatening. In the area of diabetes, which in the U.S. alone affects 25.8 million people according to the American Diabetes Association, self-testing one's blood sugar can be an important tool in preventing complications. Blood sugar tests are traditionally performed with a portable electronic device that measures sugar levels in a small drop of blood obtained by pricking the skin with a small needle and provides important information for diabetes management.
Among those who take insulin to manage Type 2 diabetes, doctors may recommend blood sugar testing one or more times a day, depending on the number of insulin doses taken. Testing is commonly done before meals, after fasting for at least eight hours, and sometimes after meals.
A recent Johns Hopkins study pointed out the need for those with Type 2 diabetes to monitor blood sugar levels more than twice a day, as suggested by the International Diabetes Federation. This recommendation is based on several recent research reports suggesting that sustained elevated blood sugar levels might increase the risk of heart disease and other diseases. Researchers say blood sugar levels exceeding 150 milligrams per deciliter on a sustained basis increase the risk of developing cardiovascular disease and stroke.
Twice daily (or more) to stick oneself with needles for self-testing? Ouch! But it's not all bad news: in fact, compliance is about to get more manageable, thanks to a man named Avner Gal and his team at Israel-based Integrity Applications, Inc.
Gal, an electrical engineer and retired commander from the Israeli Navy, is co-founder, President and CEO of Integrity Applications. Integrity has developed a painless blood glucose testing device—GlucoTrack®. This noninvasive blood glucose monitor is designed for everyone, regardless of age or body type, with either Type 1 or Type 2 diabetes. GlucoTrack removes the two most frequent "excuses" people make for not complying as they should—pain and cost—since no disposable needles are required.
GlucoTrack—with a patented combination of ultrasonic, electromagnetic and thermal technologies—provides clinically acceptable accuracy in blood glucose measurement. A small sensor clips comfortably to the earlobe, activating a proprietary algorithm, and the blood glucose level is calculated. The result is displayed on a small portable unit, as well as verbally announced. The company intends to seek FDA approval for GlucoTrack here in the United States.
For more on GlucoTrack, visit integrity-app.com, which paid for the writing and dissemination of this release.
Laura Radocaj, Dian Griesel Int'l. 212.825.3210
|SOURCE Integrity Applications|
Copyright©2012 PR Newswire.
All rights reserved